101 related articles for article (PubMed ID: 9490139)
1. [Outcome of nephrogenic metaplasia of the bladder in kidney transplant recipients].
Karam G; Gaschignard N; Hourmant M; Prunet D; Garcia S; Le Normand L; Buzelin F; Glémain P; Buzelin JM
Prog Urol; 1997 Dec; 7(6):948-52. PubMed ID: 9490139
[TBL] [Abstract][Full Text] [Related]
2. [Nephrogenic metaplasia of the bladder in renal transplant patients].
Buzelin F; Hourmant MY; Audoin AF; Karam G; Philippot D
J Urol (Paris); 1988; 94(7):323-7. PubMed ID: 3065414
[TBL] [Abstract][Full Text] [Related]
3. [Bladder nephrogenic metaplasia: circumstances of discovery, predisposing factors, and clinical course in 7 cases diagnosed between 1988 and 2000].
Ducrocq S; Bruniau A; Cordonnier C; Demailly M; Petit J; Saint F
Prog Urol; 2003 Sep; 13(4):613-7. PubMed ID: 14650292
[TBL] [Abstract][Full Text] [Related]
4. Derivation of nephrogenic adenomas from renal tubular cells in kidney-transplant recipients.
Mazal PR; Schaufler R; Altenhuber-Müller R; Haitel A; Watschinger B; Kratzik C; Krupitza G; Regele H; Meisl FT; Zechner O; Kerjaschki D; Susani M
N Engl J Med; 2002 Aug; 347(9):653-9. PubMed ID: 12200552
[TBL] [Abstract][Full Text] [Related]
5. Nephrogenic metaplasia: long-term haemodialysis and anuria as potential risk factors and reversibility with renal transplantation.
Thong W; Hinsch R; Clouston A; Nicol D
Nephrol Dial Transplant; 1995 Nov; 10(11):2101-3. PubMed ID: 8643175
[TBL] [Abstract][Full Text] [Related]
6. Urothelial metaplasia of the bladder mucosa. Nephroid-colonic- and signet-ring cell metaplasia.
Kvist E; Sjølin KE
APMIS; 1990 Apr; 98(4):287-93. PubMed ID: 2354049
[TBL] [Abstract][Full Text] [Related]
7. The course of hepatitis C virus infection in pretransplantation anti-hepatitis C virus-negative renal transplant recipients: a retrospective follow-up study.
Delladetsima I; Psichogiou M; Sypsa V; Psimenou E; Kostakis A; Hatzakis A; Boletis JN
Am J Kidney Dis; 2006 Feb; 47(2):309-16. PubMed ID: 16431260
[TBL] [Abstract][Full Text] [Related]
8. [Nephrogenic metaplasia of the urinary tract].
Fournier G
Prog Urol; 1996 Dec; 6(6):861-8. PubMed ID: 9235170
[TBL] [Abstract][Full Text] [Related]
9. Latent IgA deposition from donor kidney is the major risk factor for recurrent IgA nephropathy in renal transplantation.
Moriyama T; Nitta K; Suzuki K; Honda K; Horita S; Uchida K; Yumura W; Tanabe K; Toma H; Nihei H; Yamaguchi Y
Clin Transplant; 2005; 19 Suppl 14():41-8. PubMed ID: 15955168
[TBL] [Abstract][Full Text] [Related]
10. Possible contribution of cytomegalovirus infection to the high risk of (recurrent) venous thrombosis after renal transplantation.
Lijfering WM; de Vries AP; Veeger NJ; van Son WJ; Bakker SJ; van der Meer J
Thromb Haemost; 2008 Jan; 99(1):127-32. PubMed ID: 18217144
[TBL] [Abstract][Full Text] [Related]
11. Delayed onset of severe hepatitis C-related liver damage following liver transplantation: a matter of concern?
Berenguer M; Aguilera V; Prieto M; Carrasco D; Rayón M; San Juan F; Landaverde C; Mir J; Berenguer J
Liver Transpl; 2003 Nov; 9(11):1152-8. PubMed ID: 14586875
[TBL] [Abstract][Full Text] [Related]
12. [A bladder nephrogenic adenoma. A case report].
Llanes González L; Martín Osés E; Fernández González I; Rodríguez Barbero JM; Ruiz Rubio JL; Llorente Abarca C; Berenguer Sánchez A
Arch Esp Urol; 1998 Nov; 51(9):923-5. PubMed ID: 9887566
[TBL] [Abstract][Full Text] [Related]
13. Frequency of recurrent lupus nephritis among ninety-seven renal transplant patients during the cyclosporine era.
Stone JH; Millward CL; Olson JL; Amend WJ; Criswell LA
Arthritis Rheum; 1998 Apr; 41(4):678-86. PubMed ID: 9550477
[TBL] [Abstract][Full Text] [Related]
14. Chronic allograft nephropathy: expression and localization of PAI-1 and PPAR-gamma.
Revelo MP; Federspiel C; Helderman H; Fogo AB
Nephrol Dial Transplant; 2005 Dec; 20(12):2812-9. PubMed ID: 16221712
[TBL] [Abstract][Full Text] [Related]
15. Nephrogenic adenoma in renal transplant recipients: a truly benign lesion?
Pycha A; Mian C; Reiter WJ; Brössner C; Haitel A; Wiener H; Maier U; Marberger M
Urology; 1998 Nov; 52(5):756-61. PubMed ID: 9801094
[TBL] [Abstract][Full Text] [Related]
16. Effect of cytomegalovirus viremia on subclinical rejection or interstitial fibrosis and tubular atrophy in protocol biopsy at 3 months in renal allograft recipients managed by preemptive therapy or antiviral prophylaxis.
Reischig T; Jindra P; Hes O; Bouda M; Kormunda S; Treska V
Transplantation; 2009 Feb; 87(3):436-44. PubMed ID: 19202451
[TBL] [Abstract][Full Text] [Related]
17. Molecular evidence for progression of nephrogenic metaplasia of the urinary bladder to clear cell adenocarcinoma.
Hartmann A; Junker K; Dietmaier W; Schröder S; Lopez D; Hofstädter F; Blaszyk H
Hum Pathol; 2006 Jan; 37(1):117-20. PubMed ID: 16360424
[TBL] [Abstract][Full Text] [Related]
18. Nephrogenic metaplasia of the bladder in renal transplant recipients. Case report.
Duun S; Kirkeby L; Carstensen JM
Scand J Urol Nephrol; 1995 Mar; 29(1):109-11. PubMed ID: 7618042
[TBL] [Abstract][Full Text] [Related]
19. Late anastomotic leaks in pancreas transplant recipients - clinical characteristics and predisposing factors.
Nath DS; Gruessner A; Kandaswamy R; Gruessner RW; Sutherland DE; Humar A
Clin Transplant; 2005 Apr; 19(2):220-4. PubMed ID: 15740558
[TBL] [Abstract][Full Text] [Related]
20. [Risk factors and pathogenetic mechanisms of left ventricular hypertrophy in progressive chronic kidney disease and after transplantation of the kidney].
Tomilina NA; Storozhakov GI; Gendlin GE; Badaeva SV; Zhidkova DA; Kim IG; Borisovskaia SV; Loss KE; Fedorova ND
Ter Arkh; 2007; 79(6):34-40. PubMed ID: 17684964
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
